Systemic azoles for asthma with fungal sensitisation.

IF 11.1 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Cochrane Database of Systematic Reviews Pub Date : 2026-09-30 DOI:10.1002/14651858.CD016394

Yosuke Fukuda, Tetsuya Homma, Yoshihisa Miyamoto, Norio Watanabe

引用次数: 0

Abstract

Objectives: This is a protocol for a Cochrane review (intervention). The objectives are as follows: To assess the effects of adding systemic azoles to standard asthma care for people with asthma who have evidence of fungal sensitisation (including severe asthma with fungal sensitisation and allergic bronchopulmonary aspergillosis/allergic bronchopulmonary mycosis).

查看原文本刊更多论文

全身性唑类药物治疗真菌致敏哮喘。

目的：这是一个Cochrane综述（干预）的方案。目的如下：评估在有真菌致敏证据的哮喘患者（包括伴有真菌致敏和过敏性支气管肺曲霉病/过敏性支气管肺真菌病的严重哮喘）的标准哮喘护理中添加全身性唑的效果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cochrane Database of Systematic Reviews 医学-医学：内科

CiteScore

10.60

自引率

2.40%

发文量

173

审稿时长

1-2 weeks

期刊介绍： The Cochrane Database of Systematic Reviews (CDSR) stands as the premier database for systematic reviews in healthcare. It comprises Cochrane Reviews, along with protocols for these reviews, editorials, and supplements. Owned and operated by Cochrane, a worldwide independent network of healthcare stakeholders, the CDSR (ISSN 1469-493X) encompasses a broad spectrum of health-related topics, including health services.